Recruiting

Registry

Sponsor:

Lymphoma and Leukemia Society

Code:

NCT04806295

Conditions

Blood Cancer

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

any/all treatments for blood cancer

Study Details

Brief summary:

The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.

Conditions

Blood Cancer

Study ID

NCT04806295

Start date

Jul 24, 2017

Status verified date

Apr, 2022

Completion date

Jul 23, 2027

Anticipated

Primary completion date

Jul 23, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

People with blood cancer, before, during, and after blood cancer treatments.

Exclusion Criteria:

People unable or unwilling to sign informed consent.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Interventions

any/all treatments for blood cancer

Following people undergoing any/all treatments for blood cancer.

Primary outcome measure

  • LLS will monitor outcomes of people being treated for blood cancer. [ Time Frame: 10 years ]

Central Contacts and Locations

Central contacts

Larry Saltzman, MD

844-696-7228larry.saltzman@lls.org

Brian J Chadwick, BS RN

9144145788chadwickbj@gmail.com

Locations

Lymphoma and Leukemia Society

Recruiting

Rye Brook, New York, United States, 10573

Contacts

Larry Saltzman, MD

844-696-7228larry.saltzman@lls.org

Brian J Chadwick, BS RN

9144145788chadwickbj@gmail.com

More Information

Sponsor

Lymphoma and Leukemia Society

Last update posted

Apr 7, 2022

Last verified

Apr, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Lymphoma and Leukemia Society on 2022-04-07.